SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
AMENDED SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 19)*
Genta Incorporated
(Name of Issuer)
Common Stock, par value $.001 per share
(Title of Class of Securities)
372 45 M 20 7
(CUSIP Number)
Paramount Capital Asset Management, Inc.
c/o Lindsay A. Rosenwald, M.D.
787 Seventh Avenue
New York, NY 10019
(212) 554-4300
(Name, Address and Telephone Number of Person Authorized to Receive Notices and
Communications)
February 13, 2004
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following: |_|
Note: Six copies of this statement, including all exhibits, should be filed with
the Commission. See Rule 13d-1(a) for other parties to whom copies are to be
sent.
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
Page 1 of 19
CUSIP NO. 372 45 M 20 7 SCHEDULE 13D Page 2 of 19 Pages
--------------------------------------------------------------------------------
1 NAMES OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Paramount Capital Asset Management, Inc.
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) |_|
(b) |X|
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
OO (see Item 3)
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEM 2(d) or 2(e) |_|
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
--------------------------------------------------------------------------------
7 SOLE VOTING POWER
None
--------------------------------------------------------
NUMBER OF 8 SHARED VOTING POWER
SHARES
BENEFICIALLY 14,771,232
OWNED BY --------------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING
PERSON None
WITH --------------------------------------------------------
10 SHARED DISPOSITIVE POWER
14,771,232
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
14,771,232
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 11 EXCLUDES CERTAIN SHARES*
|_|
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
19.9%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
CO
--------------------------------------------------------------------------------
Page 2 of 19
CUSIP NO. 372 45 M 20 7 SCHEDULE 13D Page 3 of 19 Pages
--------------------------------------------------------------------------------
1 NAMES OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Aries Select I, LLC
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) |_|
(b) |X|
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
OO (see Item 3)
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEM 2(d) or 2(e) |_|
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
--------------------------------------------------------------------------------
7 SOLE VOTING POWER
None
--------------------------------------------------------
NUMBER OF 8 SHARED VOTING POWER
SHARES
BENEFICIALLY None
OWNED BY --------------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING
PERSON None
WITH --------------------------------------------------------
10 SHARED DISPOSITIVE POWER
None
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
None
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 11 EXCLUDES CERTAIN SHARES*
|_|
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
PN
--------------------------------------------------------------------------------
Page 3 of 19
CUSIP NO. 372 45 M 20 7 SCHEDULE 13D Page 4 of 19 Pages
--------------------------------------------------------------------------------
1 NAMES OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Aries Select II, LLC
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) |_|
(b) |X|
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
OO (see Item 3)
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEM 2(d) or 2(e) |_|
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
--------------------------------------------------------------------------------
7 SOLE VOTING POWER
None
--------------------------------------------------------
NUMBER OF 8 SHARED VOTING POWER
SHARES
BENEFICIALLY None
OWNED BY --------------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING
PERSON None
WITH --------------------------------------------------------
10 SHARED DISPOSITIVE POWER
None
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
None
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 11 EXCLUDES CERTAIN SHARES*
|_|
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
PN
--------------------------------------------------------------------------------
Page 4 of 19
CUSIP NO. 372 45 M 20 7 SCHEDULE 13D Page 5 of 19 Pages
--------------------------------------------------------------------------------
1 NAMES OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Aries Select, Ltd.
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) |_|
(b) |X|
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
OO (see Item 3)
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEM 2(d) or 2(e) |_|
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Cayman Islands
--------------------------------------------------------------------------------
7 SOLE VOTING POWER
None
--------------------------------------------------------
NUMBER OF 8 SHARED VOTING POWER
SHARES
BENEFICIALLY None
OWNED BY --------------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING
PERSON None
WITH --------------------------------------------------------
10 SHARED DISPOSITIVE POWER
None
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
None
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 11 EXCLUDES CERTAIN SHARES*
|_|
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
OO (see Item 2)
--------------------------------------------------------------------------------
Page 5 of 19
CUSIP NO. 372 45 M 20 7 SCHEDULE 13D Page 6 of 19 Pages
--------------------------------------------------------------------------------
1 NAMES OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Aries Domestic Fund, L.P.
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) |_|
(b) |X|
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
OO (see Item 3)
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEM 2(d) or 2(e) |_|
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
--------------------------------------------------------------------------------
7 SOLE VOTING POWER
None
--------------------------------------------------------
NUMBER OF 8 SHARED VOTING POWER
SHARES
BENEFICIALLY 5,897,054
OWNED BY --------------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING
PERSON None
WITH --------------------------------------------------------
10 SHARED DISPOSITIVE POWER
5,897,054
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
5,897,054
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 11 EXCLUDES CERTAIN SHARES*
|_|
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
7.9%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
PN
--------------------------------------------------------------------------------
Page 6 of 19
CUSIP NO. 372 45 M 20 7 SCHEDULE 13D Page 7 of 19 Pages
--------------------------------------------------------------------------------
1 NAMES OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Aries Domestic Fund II, LP
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) |_|
(b) |X|
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
OO (see Item 3)
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEM 2(d) or 2(e) |_|
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
--------------------------------------------------------------------------------
7 SOLE VOTING POWER
None
--------------------------------------------------------
NUMBER OF 8 SHARED VOTING POWER
SHARES
BENEFICIALLY 656,191
OWNED BY --------------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING
PERSON None
WITH --------------------------------------------------------
10 SHARED DISPOSITIVE POWER
656,191
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
656,191
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 11 EXCLUDES CERTAIN SHARES*
|_|
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0.8%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
PN
--------------------------------------------------------------------------------
Page 7 of 19
CUSIP NO. 372 45 M 20 7 SCHEDULE 13D Page 8 of 19 Pages
--------------------------------------------------------------------------------
1 NAMES OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
The Aries Master Fund II
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) |_|
(b) |X|
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
OO (see Item 3)
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEM 2(d) or 2(e) |_|
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Cayman Islands
--------------------------------------------------------------------------------
7 SOLE VOTING POWER
None
--------------------------------------------------------
NUMBER OF 8 SHARED VOTING POWER
SHARES
BENEFICIALLY 8,003,589
OWNED BY --------------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING
PERSON None
WITH --------------------------------------------------------
10 SHARED DISPOSITIVE POWER
8,003,589
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
8,003,589
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 11 EXCLUDES CERTAIN SHARES*
|_|
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
10.8%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
OO (see Item 2)
--------------------------------------------------------------------------------
Page 8 of 19
CUSIP NO. 372 45 M 20 7 SCHEDULE 13D Page 9 of 19 Pages
--------------------------------------------------------------------------------
1 NAMES OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Lindsay A. Rosenwald
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) |_|
(b) |X|
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
OO (see Item 3)
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEM 2(d) or 2(e) |_|
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
--------------------------------------------------------------------------------
7 SOLE VOTING POWER
3,325,522
--------------------------------------------------------
NUMBER OF 8 SHARED VOTING POWER
SHARES
BENEFICIALLY 14,771,232
OWNED BY --------------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING
PERSON 3,325,522
WITH --------------------------------------------------------
10 SHARED DISPOSITIVE POWER
14,771,232
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
18,096,754
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 11 EXCLUDES CERTAIN SHARES*
|_|
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
23.3%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
OO (see Item 2)
--------------------------------------------------------------------------------
Page 9 of 19
This Amendment No. 19 amends and supplements the following items of the
Statement on Schedule 13D filed by certain of the reporting persons, dated
February 24, 1997, as amended to date (the "Schedule").
ITEM 2. IDENTITY AND BACKGROUND
Item 2 is hereby amended in its entirety to read as follows:
(a) This statement is filed on behalf of Paramount Capital Asset
Management, Inc. ("PCAM"), Aries Select, Ltd. ("Aries Select"),
Aries Select, LLC ("AS1") and Dr. Lindsay A. Rosenwald (together
with PCAM and Aries Select the "Aries Reporting Persons"), Aries
Select II, LLC ("AS2"), Aries Domestic Fund, L.P. ("ADF1"), The
Aries Master Fund II, a Cayman Island exempted company ("AMF2"), and
Aries Domestic Fund II, L.P. ("ADF2" and, together with the Aries
Reporting Persons, the "Filing Persons"). See attached Exhibit A
which is a copy of their agreement in writing to file this statement
jointly on behalf of each of them. The Filing Persons have made, and
will continue to make, their own investment decisions.
(b) The business address of Dr. Rosenwald, PCAM, Aries Select, AS1, AS2,
Aries Domestic and Aries Domestic II is 787 Seventh Avenue, 48th
Floor, New York, New York 10019. The business address for Aries
Select and AMF2 is c/o Fortis Fund Services, P.O. Box 2003, British
American Centre, Phase 3, Dr. Roy's Drive, George Town, Grand
Cayman.
(c) Dr. Rosenwald is an investment banker, venture capitalist, fund
manager and sole shareholder of PCAM,1 a Subchapter S corporation
incorporated in the State of Delaware. PCAM is the managing member
of each of AS1 and AS2, the General Partner of Aries Domestic and
Aries Domestic II, each a limited partnership organized under the
laws of Delaware and the investment manager to AMF2 and Aries
Select2, each a Cayman Island exempted company.
(d) The Filing Persons and their respective officers, directors, general
partners, investment managers, and trustees have not, during the
five years prior to the date hereof, been convicted in a criminal
proceeding (excluding traffic violations or similar misdemeanors).
(e) The Filing Persons and their respective officers, directors, general
partners, investment managers, and trustees have not been, during
the five years prior to the date hereof, parties to a civil
proceeding of a judicial or administrative body of competent
jurisdiction, as a result of which such person was or is subject to
a judgment, decree or final order enjoining future violations of, or
prohibiting or mandating activities subject to, Federal or State
securities laws or funding any violation with respect to such laws.
--------
1 Please see Exhibit B, filed herewith, indicating the executive officers
and directors of PCAM and providing information called for by Items 2-6 of
this statement as to said officers and directors.
2 Please see Exhibit C indicating the executive officers and directors of
AMF2 and Aries Select and providing information called for by Items 2-6 of
this statement as to said officers and directors.
Page 10 of 19
(f) Dr. Rosenwald is a citizen of the United States.
ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION
The information contained in Item 3 to the Schedule is hereby amended by
adding the following:
On February 13, 2004, Aries Select converted 158,805 shares of Series A
Convertible Preferred Stock into 1,169,285 shares of common stock, AS1 converted
76,813 shares of Series A Convertible Preferred Stock into 568,163 shares of
common stock, and AS2 converted 15,905 shares of Series A Convertible Preferred
Stock into 117,645 shares of common stock.
Following such conversion, Aries Select effected an in-kind, pro rata
dividend (the "Dividend") of 5,898,583 shares of Common Stock of the Issuer
("Shares") to its shareholders. In connection with the Dividend, AMF2, which
holds 43.7% of Aries Select, was issued 2,579,191 Shares. Similarly, AS1
effected an in-kind, pro rata distribution of 2,829,843 Shares to its members.
In connection with such in-kind transfers, ADF1, which holds 67.6% of the LLC
interests of AS1, was issued 212,682 Shares. In addition, AS2 effected an
in-kind, pro rata distribution of 631,191 Shares to its members. In connection
with such in-kind transfers, ADF2, which holds 33.7% of the LLC interests of
AS2, was issued 212,682 Shares.
THE DIVIDEND AND IN-KIND PRO RATA DISTRIBUTIONS RESULTED IN A NET
REDUCTION IN THE BENEFICIAL OWNERSHIP OF DR. ROWENWALD AND PCAM OF 4,704,632
SHARES.
ITEM 4. PURPOSE OF THE TRANSACTION.
The Dividend and in-kind distributions were made in satisfaction of
certain obligations under the Aries Funds' respective operative documents. PCAM
may effect additional Dividends or in-kind distributions in the future, but has
no current intention to do so as of the date of this filing.
The Dividend and the in-kind distributions do not reflect, in any way, the
Aries Funds' view as to the condition (financial or otherwise) or prospects of
the Issuer. Moreover, Dr. Rosenwald has not sold, transferred or otherwise
disposed of any securities of the Issuer owned by him personally or through his
ownership in the Aries Funds.
DR. ROWENWALD MAY FROM TIME TO TIME IN HIS SOLE DISCRETION PURCHASE SHARES
OF THE ISSUER IN THE OPEN MARKET FOR HIS OWN PERSONAL ACCOUNT.
The Filing Persons may formulate other purposes, plans or proposals
relating to any of such securities of the Issuer to the extent deemed advisable
in light of market conditions, investment policies and other factors.
Page 11 of 19
ITEM 5. INTEREST IN SECURITIES OF ISSUER.
The information contained in Item 5 to the Schedule is hereby amended and
supplemented to read as follows:
(a) As of February 13, 2004, the Filing Persons may be deemed to
beneficially own the following:
(i) Aries Select: 0 Shares (0%);
(ii) AS1: 0 Shares (0%);
(iii) AS2: 0 Shares (0%);
(iv) AMF2: 8,003,589 Shares (10.8%);
(v) Aries Domestic: 5,897,054 Shares (7.9%);
(vi) Aries Domestic II: 656,191 Shares (0.8%);
(vii) PCAM: 14,771,232 Shares (19.9%), comprised of the Shares held
by AMF2, Aries Domestic and Aries Domestic II; and
(viii)Dr. Rosenwald: 18,096,754 Shares (23.3%), comprised of 20,000
Shares and 3,305,522 Shares issuable upon exercise of Common Stock
purchase warrants held directly by Dr. Rosenwald and 14,771,232 Shares
beneficially owned by PCAM.
Pursuant to Rule 13d-4 promulgated under the Securities
Exchange Act of 1934, as amended, each Filing Person other
than Dr. Rosenwald disclaims beneficial ownership of the
securities held by each other.
(b) Dr. Rosenwald and PCAM share the power to vote or to direct
the vote and to dispose or to direct the disposition of those
shares owned by each of AMF2, Aries Domestic and Aries
Domestic II.
(c) The Filing Persons have engaged in the following transactions
in the Common Stock of the Issuer in the past 60 days:
On December 22, 2003 AMF2, Aries Domestic and Aries Domestic
II distributed 192,127, 1,608 and 15,031 Shares, respectively
to certain redeeming investors and on February 7, 2004 AMF2,
Aries Domestic and Aries Domestic II distributed 14,294,
47,456 and 66,467 Shares, respectively to certain redeeming
investors.
Please see Item 3 for additional transactions
Page 12 of 19
(d) Dr. Rosenwald, as the sole shareholder of PCAM, has the right
to participate in the receipt of dividends from, or proceeds
from the sale of, Shares held by PCAM in accordance with his
ownership interests in PCAM.
(ii) The interest holders of AS1 have the right to participate in
the receipt of dividends from, or proceeds from the sale of,
the securities held for the account of AS1, in accordance with
their membership interests in Aries I.
(iii) The members of AS2 have the right to participate in the
receipt of dividends from, or proceeds from the sale of, the
securities held for the account of AS2 in accordance with
their membership interests in AS2.
(iv) The shareholders of Aries Select have the right to participate
in the receipt of dividends from, or proceeds from the sale
of, the securities held for the account of Aries Select in
accordance with their ownership interests in Aries Select.
(e) On February 13, 2004, Aries Select, AS1 and AS2 ceased to be
members of a group under section 13D(3) under the Securities
Exchange Act of 1934 with respect to securities of the Issuer.
ITEM 7. MATERIAL TO BE FILED AS EXHIBITS:
Exhibit A - Copy of an Agreement between the Filing Persons to file this
Statement on Schedule 13D on behalf of each of them.
Exhibit B - List of executive officers and directors of PCAM and information
called for by Items 2-6 of this statement relating to said officers
and directors.
Exhibit C - List of executive officers and directors of AMF2 Aries Select and
information called for by Items 2-6 of this statement relating to
said officers and directors.
Page 13 of 19
SIGNATURES
----------
After reasonable inquiry and to the best knowledge and belief of the
undersigned, the undersigned certify that the information set forth in this
statement is true, complete and correct.
PARAMOUNT CAPITAL ASSET MANAGEMENT, INC.
Dated: February 13, 2004
New York, NY By: ________________________________
Lindsay A. Rosenwald, M.D.
Chairman
THE ARIES MASTER FUND
By: Paramount Capital Asset Management, Inc.
Investment Manager
Dated: February 13, 2004
New York, NY By: ______________________________
Lindsay A. Rosenwald, M.D.
Chairman
ARIES DOMESTIC FUND, L.P.
By: Paramount Capital Asset Management, Inc.
General Partner
Dated: February 13, 2004
New York, NY By: ________________________________
Lindsay A. Rosenwald, M.D.
Chairman
ARIES DOMESTIC FUND II, L.P.
By: Paramount Capital Asset Management, Inc.
General Partner
Dated: February 13, 2004
New York, NY By: ________________________________
Lindsay A. Rosenwald, M.D.
Chairman
ARIES SELECT, LTD.
By: Paramount Capital Asset Management, Inc.
Investment Manager
Dated: February 13, 2004
New York, NY By: ______________________________
Lindsay A. Rosenwald, M.D.
Chairman
Page 14 of 19
ARIES SELECT DOMESTIC, LLC
By: Paramount Capital Asset Management, Inc.
Managing Member
Dated: February 13, 2004
New York, NY By: ________________________________
Lindsay A. Rosenwald, M.D.
Chairman
ARIES SELECT DOMESTIC II, LLC
By: Paramount Capital Asset Management, Inc.
Managing Member
Dated: February 13, 2004
New York, NY By: ________________________________
Lindsay A. Rosenwald, M.D.
Chairman
Dated: February 13, 2004
New York, NY _________________________________
Lindsay A. Rosenwald, M.D.
Page 15 of 19
EXHIBIT A
---------
AGREEMENT
JOINT FILING OF SCHEDULE 13D
The undersigned hereby agree jointly to prepare and file with regulatory
authorities a Schedule 13D and any amendments thereto reporting each of the
undersigned's ownership of securities of Genta Incorporated and hereby affirm
that such Schedule 13D is being filed on behalf of each of the undersigned.
PARAMOUNT CAPITAL ASSET MANAGEMENT, INC.
Dated: February 13, 2004
New York, NY By: ________________________________
Lindsay A. Rosenwald, M.D.
Chairman
THE ARIES MASTER FUND
By: Paramount Capital Asset Management, Inc.
Investment Manager
Dated: February 13, 2004
New York, NY By: ______________________________
Lindsay A. Rosenwald, M.D.
Chairman
ARIES DOMESTIC FUND, L.P.
By: Paramount Capital Asset Management, Inc.
General Partner
Dated: February 13, 2004
New York, NY By: ________________________________
Lindsay A. Rosenwald, M.D.
Chairman
ARIES DOMESTIC FUND II, L.P.
By: Paramount Capital Asset Management, Inc.
General Partner
Dated: February 13, 2004
New York, NY By: ________________________________
Lindsay A. Rosenwald, M.D.
Chairman
ARIES SELECT, LTD.
By: Paramount Capital Asset Management, Inc.
Page 16 of 19
Investment Manager
Dated: February 13, 2004
New York, NY By: ______________________________
Lindsay A. Rosenwald, M.D.
Chairman
ARIES SELECT DOMESTIC, LLC
By: Paramount Capital Asset Management, Inc.
Managing Member
Dated: February 13, 2004
New York, NY By: ________________________________
Lindsay A. Rosenwald, M.D.
Chairman
ARIES SELECT DOMESTIC II, LLC
By: Paramount Capital Asset Management, Inc.
Managing Member
Dated: February 13, 2004
New York, NY By: ________________________________
Lindsay A. Rosenwald, M.D.
Chairman
Dated: February 13, 2004
New York, NY _________________________________
Lindsay A. Rosenwald, M.D.
Page 17 of 19
EXHIBIT B
---------
The name and principal occupation or employment of each executive officer
and director of Paramount Capital is as follows:
PRINCIPAL OCCUPATION
NAME OR EMPLOYMENT
---- -------------
Lindsay A. Rosenwald, M.D. Chairman of the Board of Paramount Capital
Asset Management, Inc., Horizon BioMedical
Investments, LLC and Paramount Capital, Inc.
Peter Morgan Kash Director of Paramount Capital Asset
Management, Inc., Senior Managing Director,
Paramount Capital, Inc.
Dr. Yuichi Iwaki Director of Paramount Capital Asset
Management, Inc., Professor, University of
Southern California School of Medicine
Item 2.
During the five years prior to the date hereof, none of the above persons
(to the best of PCAM's knowledge) was convicted in a criminal proceeding
(excluding traffic violations or similar misdemeanors) or was a party to a civil
proceeding of a judicial or administrative body of competent jurisdiction, as a
result of which such person was or is subject to a judgment, decree or final
order enjoining future violations of, or prohibiting or mandating activities
subject to, Federal or State securities laws or finding any violation with
respect to such laws.
Items 3-6.
Please refer to Items 3-6 herein reporting the beneficial ownership.
Page 18 of 19
EXHIBIT C
The name and principal occupation or employment of each executive officer
and director of Aries Trust is as follows:
PRINCIPAL OCCUPATION
NAME OR EMPLOYMENT
---- -------------
Peter M. Kash Director of Paramount Capital Asset
Management, Inc., Senior Managing
Director, Paramount Capital, Inc.
Investment Manager
Wayne L. Rubin Accountant, Independent Director
Fortis Fund Services (Cayman) Administrator
Exhibit B is hereby incorporated by reference.
Item 2.
During the five years prior to the date hereof, neither of the above
persons (to the best of Aries Select's knowledge) have been convicted in a
criminal proceeding (excluding traffic violations or similar misdemeanors) or
was a party to a civil proceeding of a judicial or administrative body of
competent jurisdiction, as a result of which such person was or is subject to a
judgment, decree or final order enjoining future violations of, or prohibiting
or mandating activities subject to, Federal or State securities laws or finding
any violation with respect to such laws.
Items 3-6.
Please refer to Items 3-6 herein reporting the beneficial ownership.
Page 19 of 19